ORIC Pharmaceuticals, Inc. (FWB:4TZ) IPO
IPO
Priced at US$16.00 a share on Apr 23, 2020.
- Price
- US$16.00 a share
- Shares offered
- 7,500,000 shares of common stock
- Offering size
- US$120 million
- Underwriters' option
- Up to 1,125,000 more shares
- Underwriters
- J.P. Morgan, Citigroup, Jefferies, Guggenheim Securities · In the order on the cover
- Shares delivered
- On or about Apr 28, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 13, 2019 |
| Filed publicly | Feb 28, 2020 |
| Amended twice | Newest Apr 23, 2020 |
| Shares registered with an exchange | Apr 20, 2020 |
| Declared effective by the SEC | Apr 23, 2020 |
| Final prospectus, with the price | Apr 24, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 24, 2020 |
| EFFECT · Notice that a registration is effective | Apr 23, 2020 |
| S-1MEF · Registration of more shares for the same offering | Apr 23, 2020 |
| CERT · Exchange's certificate of listing | Apr 23, 2020 |
| CORRESP · Letter to the SEC | Apr 23, 2020 |
| S-1/A · Registration statement, amended | Apr 23, 2020 |
| UPLOAD · Letter from the SEC | Apr 22, 2020 |
| CORRESP · Letter to the SEC | Apr 21, 2020 |
| CORRESP · Letter to the SEC | Apr 21, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 20, 2020 |
| CORRESP · Letter to the SEC | Apr 20, 2020 |
| S-1/A · Registration statement, amended | Apr 20, 2020 |
| UPLOAD · Letter from the SEC | Mar 9, 2020 |
| CORRESP · Letter to the SEC | Mar 3, 2020 |
| CORRESP · Letter to the SEC | Feb 28, 2020 |
| S-1 · Registration statement | Feb 28, 2020 |
| UPLOAD · Letter from the SEC | Feb 3, 2020 |
| DRSLTR · Letter to the SEC with a draft | Jan 24, 2020 |
| DRS/A · Draft registration statement, amended | Jan 24, 2020 |
| UPLOAD · Letter from the SEC | Jan 9, 2020 |
| DRS · Draft registration statement | Dec 13, 2019 |
From the cover of the final prospectus (424B4) filed Apr 24, 2020